Coughing News and Research

RSS

Antibiotics not effective for many coughs

In a study of more than 500 patients who were suffering from acute bronchitis or pharyngitis it was found that whether or not antibiotics were prescribed, the irritating bouts of coughing still continued for an average of almost 12 days after the visit to the doctor.

22 Jun 2005

FDA approves whooping cough vaccine for adults

The U.S. Food and Drug Administration (FDA) has given drug company Sanofi-Aventis approval to sell Adacel, a vaccine against whooping cough for people ages 11 to 64.

12 Jun 2005

Study to improve symptom awareness

Asthma sufferers who have difficulty recognising the early warning signs of an attack are being targeted by a new RMIT University study.

6 Jun 2005

New vaccine against whooping cough is effective in teens and adults

The Journal of the American Medical Association (JAMA) has announced that a study to be published in the June 22/29 issue found that a new vaccine against whooping cough is effective in teens and adults, carriers of the contagious respiratory disease so dangerous to infants.

3 Jun 2005

Is winter flu worse because of exercise-induced 'window of susceptibility'?

When you exercise or work outside in winter, that dry feeling at the back of your throat indicates the cold air has irritated your throat. Racehorses share a similar experience: exercising in below-freezing air causes mild airway injury.

26 May 2005

Laughter brings on asthma

More than half of people with asthma report that their symptoms are brought on by laughter, according to a study to be presented at the American Thoracic Society International Conference on May 24.

25 May 2005

Dextromethorphan temporarily reduces the intensity of fibromyalgia

Dextromethorphan, an over-the-counter medication that silences coughs, may help fibromyalgia patients quiet over-reacting nerves that amplify ordinary touches into agony.

20 May 2005

Boostrix receives FDA approval as treatment for pertussis

GlaxoSmithKline today announced that its booster vaccine, Boostrix received approval from the United States (U.S.) Food and Drug Administration (FDA).

3 May 2005

Heart patient dies the day after a 3,800 kilometre bike ride

After bypass surgery had given him a second chance at life Broc Bebout, 57, a retired engineer, died of a heart attack the day after completing a 3,800-kilometre cross-country trip.

2 May 2005

New once a day asthma treatment approved by FDA

More than 5,000 people die from asthma each year in the United States. Although asthma deaths are infrequent, they have increased significantly during the last two decades.

4 Apr 2005

Asthma patients' immune systems respond differently with allergies

Researchers from the University of Chihuahua in Mexico report that immune systems of patients with asthma responded differently to a common laboratory challenge, depending on whether their white blood cells had been obtained during a time when they were suffering from common season allergic rhinitis or when they were free of such allergic symptoms.

3 Apr 2005

High-rise homes have the highest levels of cockroach allergens

Roaches like to live high in the sky in places like Chicago, New York City and the Bronx, according to a recent study in the Journal of Allergy and Clinical Immunology. The study, conducted by an allergist affiliated with Children's Medical Center Dallas, found high-rise homes in Northeastern cities had the highest levels of cockroach allergens -- leading to a higher incidence of asthmatic episodes.

30 Mar 2005

Evidence SARS virus may spread through the air

Two new studies present evidence that the virus causing severe acute respiratory syndrome (SARS) may spread through the air, not just through direct contact with contaminated water droplets as previous research had shown.

23 Mar 2005

Specific test key to determine whether or not allergy symptoms are really allergy-related

Many people with allergy-like symptoms could get the test they need, and the right treatments for their symptoms, from their primary care physician if managed care practice guidelines encouraged the use of the test.

23 Mar 2005

Drug combo gives lung cancer patients longer life

Preliminary results from a large randomized clinical trial, sponsored by the National Cancer Institute (NCI), by a network of researchers led by the Eastern Cooperative Oncology Group. Genentech, Inc., have shown that patients with previously untreated advanced non-squamous non-small cell lung cancer who received bevacizumab (Avastin) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Bevacizumab (Avastin) in combination with standard chemotherapy helps advanced lung cancer sufferers

Preliminary results from a large, randomized clinical trial for patients with previously untreated advanced non-squamous, non-small cell lung cancer show that those patients who received bevacizumab (AvastinTM) in combination with standard chemotherapy lived longer than patients who received the same chemotherapy without bevacizumab.

15 Mar 2005

Diesel engines are posing a serious threat to public health

Air particles emitted mainly by diesel engines are posing a serious threat to public health, warn respiratory physiotherapists in a new report published by the Chartered Society of Physiotherapy (CSP).

1 Mar 2005

Increased risk of urinary incontinence with hormone therapy

Menopausal hormone therapy (MHT), consisting of oral estrogen plus progestin or estrogen alone, considered in the past as treatment for urinary incontinenc, was until recently, credited with many benefits well beyond the indications for symptomatic relief of hot flashes, night sweats, and vaginal dryness. One of the benefits of MHT was to improve the symptoms of urinary incontinence (UI), and it has often been prescribed to treat UI.

21 Feb 2005

Bushfire warning - smoke may trigger asthma symptoms

As Australia's summer temperatures rise and the drought persists, Australia once again is facing the threat of bushfires. While bushfires already rage in South Australia and western Victoria, warnings of fire danger and bushfire ratings remain high across the country.

17 Jan 2005

Alvesco now available for asthma sufferers in the United Kingdom

Altana AG has announced that Alvesco (Ciclesonide), a novel inhaled corticosteroid (ICS) for the treatment of adults (18+ years) suffering from persistent asthma is now available for the first time in the United Kingdom (UK).

17 Jan 2005